BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8843844)

  • 1. Prenatal diagnosis of fragile X syndrome.
    Willemsen R; Oosterwijk JC; Los FJ; Galjaard H; Oostra BA
    Lancet; 1996 Oct; 348(9032):967-8. PubMed ID: 8843844
    [No Abstract]   [Full Text] [Related]  

  • 2. First trimester prenatal diagnosis of a male fetus with fragile X.
    Tommerup N; Søndergaard F; Tønnesen T; Kristensen M; Arveiler B; Schinzel A
    Lancet; 1985 Apr; 1(8433):870. PubMed ID: 2858725
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid antibody test for prenatal diagnosis of fragile X syndrome on amniotic fluid cells: a new appraisal.
    Willemsen R; Los F; Mohkamsing S; van den Ouweland A; Deelen W; Galjaard H; Oostra B
    J Med Genet; 1997 Mar; 34(3):250-1. PubMed ID: 9132500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated prenatal diagnosis of fragile X syndrome by polymerase chain reaction restriction fragment detection.
    Dobkin C; Ding X; Li S; Houck G; Nolin SL; Glicksman A; Zhong N; Jenkins EC; Brown WT
    Am J Med Genet; 1999 Apr; 83(4):338-41. PubMed ID: 10208176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphic DNA markers in prenatal diagnosis of fragile X syndrome.
    Oberlé I; Mandel JL; Boué J; Mattei MG; Mattei JF
    Lancet; 1985 Apr; 1(8433):871. PubMed ID: 2858726
    [No Abstract]   [Full Text] [Related]  

  • 6. Timing of the absence of FMR1 expression in full mutation chorionic villi.
    Willemsen R; Bontekoe CJ; Severijnen LA; Oostra BA
    Hum Genet; 2002 Jun; 110(6):601-5. PubMed ID: 12107447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A faster strategy for prenatal diagnosis of fragile X syndrome.
    Schmitt S; Giraud M; Hary J; Rival JM; Bezieau S; Boisseau P
    Prenat Diagn; 2010 Dec; 30(12-13):1217-9. PubMed ID: 20842624
    [No Abstract]   [Full Text] [Related]  

  • 8. Rapid FMR1-protein analysis of fetal blood: an enhancement of prenatal diagnostics.
    Lambiris N; Peters H; Bollmann R; Leschik G; Leisti J; Salonen R; Cobet G; Oostra BA; Willemsen R
    Hum Genet; 1999 Sep; 105(3):258-60. PubMed ID: 10987654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening for Fragile X syndrome mutations during early pregnancy--results and mothers' opinions about the gene test].
    Ryynänen M; Heinonen S; Makkonen M; Mannermaa A; Kirkinen P
    Duodecim; 1998; 22(114):2323-9. PubMed ID: 11757093
    [No Abstract]   [Full Text] [Related]  

  • 10. [Gene diagnosis of fragile X syndrome].
    Wu G; Shen Y
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):698-700. PubMed ID: 9639773
    [No Abstract]   [Full Text] [Related]  

  • 11. FMRP detection assay for the diagnosis of the fragile X syndrome.
    Willemsen R; Oostra BA
    Am J Med Genet; 2000; 97(3):183-8. PubMed ID: 11449486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal analysis of chorionic villi for foetal diagnosis in the first trimester.
    Kucheria K; Taneja N; Kulkarni V; Agarwal N
    Indian J Med Res; 1987 May; 85():589-91. PubMed ID: 3666860
    [No Abstract]   [Full Text] [Related]  

  • 13. Prenatal diagnosis of a hypermethylated full fragile X mutation in chorionic villi of a male fetus.
    Suzumori K; Yamauchi M; Seki N; Kondo I; Hori T
    J Med Genet; 1993 Sep; 30(9):785-7. PubMed ID: 8411077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis of the fragile X syndrome by the analysis of FMRP expression in blood and hair roots].
    Ramos FJ; Willemsen R
    Arch Pediatr; 2003 May; 10(5):401-2. PubMed ID: 12878331
    [No Abstract]   [Full Text] [Related]  

  • 15. Prenatal diagnosis of the fragile X syndrome: loss of mutation owing to a double recombinant or gene conversion event at the FMR1 locus.
    Losekoot M; Hoogendoorn E; Olmer R; Jansen CC; Oosterwijk JC; van den Ouweland AM; Halley DJ; Warren ST; Willemsen R; Oostra BA; Bakker E
    J Med Genet; 1997 Nov; 34(11):924-6. PubMed ID: 9391887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation represses FMR-1 transcription in fragile X syndrome.
    Sutcliffe JS; Nelson DL; Zhang F; Pieretti M; Caskey CT; Saxe D; Warren ST
    Hum Mol Genet; 1992 Sep; 1(6):397-400. PubMed ID: 1301913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal fragile X detection using cytoplasmic and nuclear-specific monoclonal antibodies.
    Jenkins EC; Wen GY; Kim KS; Zhong N; Sapienza VJ; Hong H; Chen J; Li SY; Houck GE; Ding X; Nolin SL; Dobkin CS; Brown WT
    Am J Med Genet; 1999 Apr; 83(4):342-6. PubMed ID: 10208177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fragile X syndrome: molecular aspects and prenatal diagnosis].
    Yeshaya-Shany J; Shalgi R; Mashiach S; Goldman B; Ravia Y
    Harefuah; 1995 May; 128(9):587-91. PubMed ID: 7797163
    [No Abstract]   [Full Text] [Related]  

  • 19. Current controversies in prenatal diagnosis 1: screening for fragile X syndrome.
    Yaron Y; Musci T; Cuckle H
    Prenat Diagn; 2013 Jan; 33(1):6-8. PubMed ID: 23079963
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chromosome analysis from uncultured chorionic villi obtained by transcervical aspiration during the 1st trimester of pregnancy].
    Szabó J; Herczeg J; Thurzó L; Szemere G
    Orv Hetil; 1984 Mar; 125(10):567-8, 571. PubMed ID: 6700964
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.